These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25701628)

  • 1. Development of anti-E6 pegylated lipoplexes for mucosal application in the context of cervical preneoplastic lesions.
    Lechanteur A; Furst T; Evrard B; Delvenne P; Hubert P; Piel G
    Int J Pharm; 2015 Apr; 483(1-2):268-77. PubMed ID: 25701628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEGylation of lipoplexes: The right balance between cytotoxicity and siRNA effectiveness.
    Lechanteur A; Furst T; Evrard B; Delvenne P; Hubert P; Piel G
    Eur J Pharm Sci; 2016 Oct; 93():493-503. PubMed ID: 27593989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic Liposomes Carrying HPV16 E6-siRNA Inhibit the Proliferation, Migration, and Invasion of Cervical Cancer Cells.
    Sánchez-Meza LV; Bello-Rios C; Eloy JO; Gómez-Gómez Y; Leyva-Vázquez MA; Petrilli R; Bernad-Bernad MJ; Lagunas-Martínez A; Medina LA; Serrano-Bello J; Organista-Nava J; Illades-Aguiar B
    Pharmaceutics; 2024 Jun; 16(7):. PubMed ID: 39065577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoting Vaginal Distribution of E7 and MCL-1 siRNA-Silencing Nanoparticles for Cervical Cancer Treatment.
    Lechanteur A; Furst T; Evrard B; Delvenne P; Piel G; Hubert P
    Mol Pharm; 2017 May; 14(5):1706-1717. PubMed ID: 28350964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo.
    Niu XY; Peng ZL; Duan WQ; Wang H; Wang P
    Int J Gynecol Cancer; 2006; 16(2):743-51. PubMed ID: 16681755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs.
    Koivusalo R; Krausz E; Helenius H; Hietanen S
    Mol Pharmacol; 2005 Aug; 68(2):372-82. PubMed ID: 15908516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection.
    Li B; Hu Y; Ye F; Li Y; Lv W; Xie X
    Int J Gynecol Cancer; 2010 May; 20(4):597-604. PubMed ID: 20442590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. siRNA-E6 sensitizes HPV-16-related cervical cancer through Oxaliplatin: an in vitro study on anti-cancer combination therapy.
    Shiri Aghbash P; Hemmat N; Baradaran B; Bannazadeh Baghi H
    Eur J Med Res; 2023 Jan; 28(1):42. PubMed ID: 36681850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
    Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray analysis identifies differentially expressed genes induced by human papillomavirus type 18 E6 silencing RNA.
    Min W; Wen-li M; Zhao-hui S; Ling L; Bao Z; Wen-ling Z
    Int J Gynecol Cancer; 2009 May; 19(4):547-63. PubMed ID: 19509549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific apoptosis induction in human papillomavirus-positive cervical carcinoma cells by photodynamic antisense regulation.
    Yamayoshi A; Kato K; Suga S; Ichinoe A; Arima T; Matsuda T; Kato H; Murakami A; Wake N
    Oligonucleotides; 2007; 17(1):66-79. PubMed ID: 17461764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand.
    Koivusalo R; Krausz E; Ruotsalainen P; Helenius H; Hietanen S
    Cancer Res; 2002 Dec; 62(24):7364-71. PubMed ID: 12499281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of small molecule human papillomavirus E6 inhibitors.
    Malecka KA; Fera D; Schultz DC; Hodawadekar S; Reichman M; Donover PS; Murphy ME; Marmorstein R
    ACS Chem Biol; 2014 Jul; 9(7):1603-12. PubMed ID: 24854633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-risk human papillomavirus-18 uses an mRNA sequence to synthesize oncoprotein E6 in tumors.
    García A; Maldonado G; González JL; Svitkin Y; Cantú D; García-Carrancá A; Sonenberg N; Hernández G
    Proc Natl Acad Sci U S A; 2021 Oct; 118(41):. PubMed ID: 34615711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
    Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
    J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
    Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial microRNAs against the viral E6 protein provoke apoptosis in HPV positive cancer cells.
    Bonetta AC; Mailly L; Robinet E; Travé G; Masson M; Deryckere F
    Biochem Biophys Res Commun; 2015 Oct; 465(4):658-64. PubMed ID: 26241675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Papillomavirus E6 Knockdown Restores Adenovirus Mediated-estrogen Response Element Linked p53 Gene Transfer in HeLa Cells.
    Kajitani K; Honda K; Terada H; Yasui T; Sumi T; Koyama M; Ishiko O
    Asian Pac J Cancer Prev; 2015; 16(18):8239-45. PubMed ID: 26745067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells.
    Munagala R; Kausar H; Munjal C; Gupta RC
    Carcinogenesis; 2011 Nov; 32(11):1697-705. PubMed ID: 21859835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic delivery of siRNA by actively targeted polyion complex micelles for silencing the E6 and E7 human papillomavirus oncogenes.
    Nishida H; Matsumoto Y; Kawana K; Christie RJ; Naito M; Kim BS; Toh K; Min HS; Yi Y; Matsumoto Y; Kim HJ; Miyata K; Taguchi A; Tomio K; Yamashita A; Inoue T; Nakamura H; Fujimoto A; Sato M; Yoshida M; Adachi K; Arimoto T; Wada-Hiraike O; Oda K; Nagamatsu T; Nishiyama N; Kataoka K; Osuga Y; Fujii T
    J Control Release; 2016 Jun; 231():29-37. PubMed ID: 26979870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.